Summary
Analysis of the plasma from a totally pancreatectomized patient, with antiserum 30 K, has demonstrated basal glucagon immunoreactivity (GIR) levels in the normal range (80–110 pg/ml). Neither i. v. arginine nor oral glucose affected these GIR values, thus indicating the absence of functioning pancreatic or gastrointestinal A-cells. Furthermore, filtration of whole plasma on Bio Gel P-30 showed no GIR in the 3500 MW elution volume. GIR was found to be distributed in two peaks. One peak eluted in the protein region, similarly to “big plasma glucagon” (BPG), and the second peak appeared after the glucagon-I125 marker. The protein-sized moiety was not absorbable by charcoal, and on Sephadex G-100 it eluted within the globulin region. When subjected to trypsin treatment, it yielded smaller GIR fractions. According to these criteria, it can be assumed that this component is identical to BPG. Therefore, an extrapancreatic source for BPG is suggested. On the other hand, the presence of fasting hyperglycaemia in this patient indicates that insulin deficiency by itself suffices to raise blood sugar to diabetic levels.
Article PDF
Similar content being viewed by others
References
Valverde, I., Villanueva, M. L., Lozano, I., Marco, J.: Presence of glucagon immunoreactivity in the globulin fraction of human plasma (“Big plasma glucagon”). J. clin. Endocr.39, 1090–1098 (1974)
Weir, G. C., Knowlton, S. D., Martin, D. B.: High molecular weight glucagon-like immunoreactivity in plasma. J. clin. Endocr.40, 296–302 (1975)
Vranic, M., Pek. S., Kawamori, R.: Increased “glucagon immunoreactivity” in plasma of totally depancreatized dogs. Diabetes23, 905–912 (1974)
Matsuyama, T., Foa, P.P.: Plasma glucose, insulin, pancreatic and enteroglucagon levels in normal and depancreatized dogs. Proc. Soc. exp. Biol. (N. Y.)147, 97–102 (1974)
Mashiter, K., Harding, P. E., Chou, M., Mashiter, G. D., Stout, J., Diamond, D., Field, J. B.: Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. Endocrinology96, 678–693 (1975)
Dobbs, R., Sakurai, H., Sasaki, H., Faloona, G., Valverde, I., Baetens, D., Orci, L., Unger, R. H.: Glucagon: role in the hyperglycemia of diabetes mellitus. Science187, 544–547 (1975)
Penhos, J. C., Ezequiel, M., Lepp, A., Ramey, E. R.: Plasma immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) after evisceration with and without a functional liver. Diabetes24, 637–640 (1975)
Sasaki, H., Rubalcava, B., Baetens, D., Blazquez, E., Srikant, C. B., Orci, L., Unger, R. H.: Identification of glucagon in the gastrointestinal tract. J. clin. Invest.56, 135–145 (1975)
Marco, J., Calle, C., Román, D., Díaz-Fierros, M., Villanueva, M. L., Valverde, I.: Hyperglucagonism induced by glucocorticoid treatment in man. New Engl. J. Med.288, 128–131 (1973)
Weir, G. G., Turner, R. G., Martin, D. B.: Glucagon radioimmunoassay using antiserum 30 K: Interference by plasma. Horm. Metab. Res.5, 241–244 (1973)
Faloona, G. R., Unger, R. H.: Glucagon. In: Methods of hormone radioimmunoassay (eds. B. M. Jaffe, H. R. Behrman), pp. 317–330. New York: Academic Press, Inc. 1974
Rigopoulou, D., Valverde, I., Marco, J., Faloona, G., Unger, R. H.: Large glucagon immunoreactivity in extracts of pancreas. J. biol. Chem.245, 496–501 (1970)
Müller, W. A., Brennan, M. F., Tan, M.H., Aoki, T.T.: Studies of glucagon secretion in pancreatectomized patients. Diabetes23, 512–516 (1974)
Gerich, J. E., Schneider, V., Dippe, S. E., Langlois, M., Noacco, C., Karam, J. E., Forsham, P. H.: Characterization of the glucagon response to hypoglycemia in man. J. clin. Endocr.38, 77–82 (1974)
Unger, R. H., Orci, L.: The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet 1975I, 14–16
Barnes, A. J., Bloom, S. R.: Pancreatectomized man: a model for diabetes without glucagon. Lancet 1976I, 219–221
Author information
Authors and Affiliations
Additional information
Supported in part by a research grant (12-894-74) from the Instituto Nacional de Previsión, Spain, by a research contract (No. 1551/RB) from the International Atomic Energy Agency, Vienna, Austria, and by a gift from the Alexander von Humboldt Stiftung, Bonn-Bad Godesberg, Federal Republic of Germany
Rights and permissions
About this article
Cite this article
Villanueva, M.L., Hedo, J.A. & Marco, J. Plasma glucagon immunoreactivity in a totally pancreatectomized patient. Diabetologia 12, 613–616 (1976). https://doi.org/10.1007/BF01220639
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01220639